Increased risk of secondary bladder cancer after radiation therapy for endometrial cancer

Abstract To investigate the effect of radiation therapy (RT) after endometrial cancer (EC) diagnosis on the risk of occurring secondary bladder cancer (SBC) as well as on the survival outcome of those patients who suffered with SBC. Data was extracted from the Surveillance, Epidemiology, and End Res...

Full description

Bibliographic Details
Main Authors: Li Wen, Guansheng Zhong, Min Ren
Format: Article
Language:English
Published: Nature Portfolio 2022-01-01
Series:Scientific Reports
Online Access:https://doi.org/10.1038/s41598-022-05126-w
_version_ 1819261134242316288
author Li Wen
Guansheng Zhong
Min Ren
author_facet Li Wen
Guansheng Zhong
Min Ren
author_sort Li Wen
collection DOAJ
description Abstract To investigate the effect of radiation therapy (RT) after endometrial cancer (EC) diagnosis on the risk of occurring secondary bladder cancer (SBC) as well as on the survival outcome of those patients who suffered with SBC. Data was extracted from the Surveillance, Epidemiology, and End Results database between 1973 and 2015. Chi-squared test was utilized to compare clinicopathological characteristics among different groups. The Fine and Gray’s competing risk model was utilized to assess cumulative incidence and risk of occurring SBC in EC survivors. The Kaplan–Meier method and the Cox regression model were used for survival analysis. As a result, a total of 108,060 EC patients were included, among which 37,118 (34.3%) patients received RT while others did not. The incidence of SBC was 1.31%, 1.76% and 0.96% among patients who received prior brachytherapy, external-beam radiotherapy (EBRT) and others, respectively. Both of the EBRT (standardized incidence ratio (SIR) = 2.24, 95% CI [1.94–2.58]) and brachytherapy (SIR = 1.76, 95% CI [1.44–2.13]) group had a higher incidence of SBC than the general population in USA. The competing risk analysis demonstrated that receiving EBRT (HR = 1.97, 95% CI [1.64–2.36]) or brachytherapy (HR = 1.46, 95% CI [1.14–1.87]) were all independent risk factors for developing SBC. A survival detriment was only observed in SBC patients who received prior EBRT after EC diagnosis, but not for brachytherapy, when compared with those who did not undergo RT. Additionally, there were no significant survival differences between primary bladder cancer and SBC with or without prior RT history. Patients who underwent RT after EC had an increased risk of developing bladder cancer as secondary primary cancer. The prognosis of these SBC patients varied depending on types of RT that received after EC diagnosis.
first_indexed 2024-12-23T19:36:58Z
format Article
id doaj.art-9e58cea8064840a0be465ad18c9f11ee
institution Directory Open Access Journal
issn 2045-2322
language English
last_indexed 2024-12-23T19:36:58Z
publishDate 2022-01-01
publisher Nature Portfolio
record_format Article
series Scientific Reports
spelling doaj.art-9e58cea8064840a0be465ad18c9f11ee2022-12-21T17:33:46ZengNature PortfolioScientific Reports2045-23222022-01-0112111010.1038/s41598-022-05126-wIncreased risk of secondary bladder cancer after radiation therapy for endometrial cancerLi Wen0Guansheng Zhong1Min Ren2Department of Prenatal Diagnosis and Screening Center, Hangzhou Women’s Hospital (Hangzhou Maternity and Child Health Care Hospital)Department of Breast Surgery, The First Affiliated Hospital, College of Medicine, Zhejiang UniversityDepartment of Obstetrics and Gynecology, Zhejiang HospitalAbstract To investigate the effect of radiation therapy (RT) after endometrial cancer (EC) diagnosis on the risk of occurring secondary bladder cancer (SBC) as well as on the survival outcome of those patients who suffered with SBC. Data was extracted from the Surveillance, Epidemiology, and End Results database between 1973 and 2015. Chi-squared test was utilized to compare clinicopathological characteristics among different groups. The Fine and Gray’s competing risk model was utilized to assess cumulative incidence and risk of occurring SBC in EC survivors. The Kaplan–Meier method and the Cox regression model were used for survival analysis. As a result, a total of 108,060 EC patients were included, among which 37,118 (34.3%) patients received RT while others did not. The incidence of SBC was 1.31%, 1.76% and 0.96% among patients who received prior brachytherapy, external-beam radiotherapy (EBRT) and others, respectively. Both of the EBRT (standardized incidence ratio (SIR) = 2.24, 95% CI [1.94–2.58]) and brachytherapy (SIR = 1.76, 95% CI [1.44–2.13]) group had a higher incidence of SBC than the general population in USA. The competing risk analysis demonstrated that receiving EBRT (HR = 1.97, 95% CI [1.64–2.36]) or brachytherapy (HR = 1.46, 95% CI [1.14–1.87]) were all independent risk factors for developing SBC. A survival detriment was only observed in SBC patients who received prior EBRT after EC diagnosis, but not for brachytherapy, when compared with those who did not undergo RT. Additionally, there were no significant survival differences between primary bladder cancer and SBC with or without prior RT history. Patients who underwent RT after EC had an increased risk of developing bladder cancer as secondary primary cancer. The prognosis of these SBC patients varied depending on types of RT that received after EC diagnosis.https://doi.org/10.1038/s41598-022-05126-w
spellingShingle Li Wen
Guansheng Zhong
Min Ren
Increased risk of secondary bladder cancer after radiation therapy for endometrial cancer
Scientific Reports
title Increased risk of secondary bladder cancer after radiation therapy for endometrial cancer
title_full Increased risk of secondary bladder cancer after radiation therapy for endometrial cancer
title_fullStr Increased risk of secondary bladder cancer after radiation therapy for endometrial cancer
title_full_unstemmed Increased risk of secondary bladder cancer after radiation therapy for endometrial cancer
title_short Increased risk of secondary bladder cancer after radiation therapy for endometrial cancer
title_sort increased risk of secondary bladder cancer after radiation therapy for endometrial cancer
url https://doi.org/10.1038/s41598-022-05126-w
work_keys_str_mv AT liwen increasedriskofsecondarybladdercancerafterradiationtherapyforendometrialcancer
AT guanshengzhong increasedriskofsecondarybladdercancerafterradiationtherapyforendometrialcancer
AT minren increasedriskofsecondarybladdercancerafterradiationtherapyforendometrialcancer